{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/ophthalmology-gene-therapy-trial-insights-senior-clinical-project-manager#webpage",
"url": "https://www.fortrea.com/insights/ophthalmology-gene-therapy-trial-insights-senior-clinical-project-manager",
"name": "Ophthalmology gene therapy trial: Insights from a Senior Clinical Project Manager",
"description": "This Fortrea case study shares insights from Adam Sgarlata, Senior Clinical Project Manager, on the management of ophthalmology gene therapy trials and the evolving landscape of ophthalmology clinical research. Drawing on more than 15 years of experience and oversight of over 90 research sites across multiple gene therapy studies, the discussion highlights the critical role of clinical project management in coordinating sponsors, sites, vendors, and patients while supporting complex ophthalmology research programs. The case study explores challenges encountered during the expansion of a large gene therapy program, including working with retina research sites new to gene therapy studies, managing complex administration processes, fostering strong site collaboration, supporting multidisciplinary teams, and maintaining effective communication across stakeholders. Through practical lessons learned and real-world experiences, the content demonstrates how clinical project management contributes to the successful delivery and growth of ophthalmology gene therapy research programs."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Ophthalmology gene therapy trial: Insights from a Senior Clinical Project Manager",
"item": "https://www.fortrea.com/insights/ophthalmology-gene-therapy-trial-insights-senior-clinical-project-manager"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/ophthalmology-gene-therapy-trial-insights-senior-clinical-project-manager#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/ophthalmology-gene-therapy-trial-insights-senior-clinical-project-manager#webpage"
},
"headline": "Ophthalmology Gene Therapy Trial: Insights from a Senior Clinical Project Manager | Fortrea Case Study",
"description": "This Fortrea case study shares insights from Adam Sgarlata, Senior Clinical Project Manager, on the management of ophthalmology gene therapy trials and the evolving landscape of ophthalmology clinical research. Drawing on more than 15 years of experience and oversight of over 90 research sites across multiple gene therapy studies, the discussion highlights the critical role of clinical project management in coordinating sponsors, sites, vendors, and patients while supporting complex ophthalmology research programs. The case study explores challenges encountered during the expansion of a large gene therapy program, including working with retina research sites new to gene therapy studies, managing complex administration processes, fostering strong site collaboration, supporting multidisciplinary teams, and maintaining effective communication across stakeholders. Through practical lessons learned and real-world experiences, the content demonstrates how clinical project management contributes to the successful delivery and growth of ophthalmology gene therapy research programs.",
"genre": "Case Study",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2026-04/ophthalmology-gene-therapy.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-04-14",
"dateModified": "2026-04-14",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/ophthalmology-gene-therapy.pdf",
"encodingFormat": "application/pdf"
}
}
]
}